John Wiley & Sons earnings release, September 3, 2026
Wiley Reports First Quarter 2027 Results;
Q1 in line with expectations and full year outlook reaffirmed
Strength in Research and AI offset by prior year comparison and softness in Learning – Emerald integration ahead of schedule
September 3, 2026 -
Hoboken, NJ – Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today reported results for the first quarter ended July 31, 2026.
First Quarter
Summary
• GAAP performance vs. prior year:
Revenue of $386 million vs. $397 million (-3%); Operating Income of $3 million vs. $31 million and Diluted Earnings Per Share (EPS) of $(0.23) vs. $0.22 largely due to restructuring charges and acquisition and integration related costs.
• Adjusted Results at constant currency
:
Revenue of $386 million vs. $397 million (-3%), with growth in Research and contributions from the Emerald acquisition offset by prior year AI licensing revenue of $29 million and market-related softness in Learning.
Adjusted Operating Income of $31 million (-9%), Adjusted EBITDA of $68 million (-4%), and Adjusted EPS of $0.44 (-10%) primarily due to revenue performance, with Adjusted EPS further impacted by higher net interest expense related to the acquisition.
• Research growth:
Strong demand to publish and output trends continue.
Revenue grew 4%, with Research Publishing up 12% (including two months from Emerald) offsetting a prior-year AI licensing comparison in Research Solutions. Adjusted EBITDA margin rose 130 basis points.
• AI and data analytics momentum:
AI licensing revenue totaled $14 million for the quarter. The pipeline continues to expand across model training, commercial licensing, and subscription knowledge feeds. Wiley became the only scientific publisher in the U.S. Department of Energy’s Genesis Mission and a founding data partner in CuspAI’s materials foundry. Wiley also launched its breakthrough Spectral Analysis API portfolio in the quarter, delivering "gold standard" chemical reference data directly into automated laboratory software pipelines.
• Cost savings:
Wiley’s continued focus on efficiency drove a 19% improvement ($8 million) in corporate expenses on an Adjusted EBITDA basis through technology transformation and restructuring.
• Returns to shareholders:
The Company increased its dividend for the 33rd consecutive year and allocated $33 million to dividends and share repurchases this quarter.
Management Commentary
“We delivered the quarter we planned for, and the momentum between Research and AI keeps building: Research is fueling the trusted content that accelerates AI, and AI is driving the productivity that accelerates Research,” said Matthew Kissner, President and CEO. “You can see it in our Research and AI pipelines, and in our selection as the only scientific publisher in the U.S. Department of Energy’s Genesis Mission and as founding data partner in CuspAI’s global materials foundry—choices that reflect not just our scale, but the quality and trust we’ve built over two centuries.
Prior year AI licensing comparisons affected both segments this quarter, particularly Learning, and we expect improvement over the balance of the year as comparisons normalize and demand in that segment stabilizes.”
Financial Summary
Please see accompanying financial tables for more detail.
Research Segment
• Research revenue of $293 million was up 4% as reported and at constant currency, with Research Publishing up 12% (CC) largely driven by the addition of Emerald ($13 million in two months) and strong growth in gold open access and AI licensing.
This was partially offset by a 30% decline (CC) in Research Solutions largely due to prior year AI licensing comparison ($16 million vs. $4 million this quarter).
• Research Adjusted EBITDA of $87 million was up 9% (CC) including a $5 million contribution from Emerald. Adjusted EBITDA margin for the quarter rose 130 basis points to 29.6%.
• During the quarter, Wiley acquired Emerald Publishing for approximately $450 million in cash, net of cash acquired, or roughly 7 times Adjusted EBITDA on a synergized basis including $30 million of targeted cost synergies. Emerald brings nearly 500 journals, thousands of book titles and case studies, and 500,000 backfile assets. The acquisition expands Wiley's portfolio to roughly 2,500 journals and establishes a top-one-or-two position across key areas of economics, business, and finance.
Learning Segment
• Learning revenue of $93 million was down 19% as reported and 20% (CC) reflecting prior year AI licensing comparison in Academic and Professional ($8 million and $5 million, respectively) and softness in consumer and corporate spending.
Q1 is Wiley’s seasonally lightest quarter in Academic.
• Learning Adjusted EBITDA of $14 million was down 56% (CC) primarily reflecting revenue performance and mix.
Corporate Expenses
“Corporate Expenses” are the portion of shared services costs not allocated to segments.
• Corporate Expenses on an Adjusted EBITDA basis improved 19% ($8 million) as reported and at constant currency driven by technology transformation and continued restructuring savings.
Balance Sheet, Cash Flow, and Capital Allocation
• Net Debt-to-EBITDA ratio (TTM) at quarter end was 2.7x compared to 1.9x in the year-ago period, reflecting higher net debt of $1,185 million vs. $746 million due to the June 1 acquisition of Emerald.
Wiley’s proforma leverage is 2.1x including Emerald synergies.
• Net Cash Used in Operating Activities was $55 million compared to $85 million in the prior year, reflecting the anticipated recovery in cash collection related to late Q4 renewal signings.
Note, Wiley’s regular use of cash in the first half of the fiscal year is driven by the timing of cash collections for annual journal renewals, which are concentrated in Q3 and Q4.
• ... (truncated)prior year.
Capex was $14 million, down $1 million.
• Returns to Shareholders: Wiley allocated $33 million toward dividends and share repurchases. $15 million was allocated to share repurchases, up from $14 million in the prior-year period, and the dividend was raised for the 33rd consecutive year.
Fiscal 2027 Outlook
Wiley is reaffirming its full year outlook based on key leading indicators, including strong pipelines in publishing and AI licensing, and anticipated cost savings.
*Organic Revenue Growth” excludes the effects of the Emerald acquisition and currency movements.
All other metrics include the addition of Emerald.
Emerald is projected to add $78 million to Revenue (11 months of Fiscal Year) and be accretive to Adjusted EPS by approximately $0.10 and dilutive to Free Cash Flow by $15 million (the Emerald acquisition is expected to turn Free Cash Flow accretive in Fiscal 2028)
• Organic Revenue Growth
- driven by expected core growth in Research and another strong year for AI and data analytics growth initiatives.
• Adjusted EBITDA Margin – reflecting anticipated cost savings and ongoing efficiency gains balanced with high-return, sustainable growth investment.
• Adjusted EPS – growth expectation driven by higher expected Adjusted Operating Income
• Free Cash Flow – driven by expected cash earnings growth partially offset by year 1 dilution from Emerald ($15M), higher capex ($80M vs. $65M in FY26), expected restructuring costs, and higher cash taxes.
Earnings Conference Call
Scheduled for today, September 3 at 10:00 am (ET).
Access webcast at Investor Relations at investors.wiley.com, or directly at http://events.q4inc.com/attendee/638218988.
North American callers, please dial (833) 461-5787 and enter the meeting ID: 638 218 988.
International callers, please dial (585) 542-9983 and enter the meeting ID: 638 218 988.
About Wiley
Wiley (NYSE: WLY) is a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning. With more than 200 years at the center of the scholarly ecosystem, Wiley combines trusted publishing heritage with AI-powered platforms to transform how knowledge is discovered, accessed, and applied. From individual researchers and students to Fortune 500 R&D teams, Wiley enables the transformation of scientific breakthroughs into real-world impact. From knowledge to impact—Wiley is redefining what's possible in science and learning. Visit us at
Wiley.com and
Investors.Wiley.com. Follow us on
Facebook,
X,
LinkedIn and
Non-GAAP Financial Measures
Wiley provides non-GAAP financial measures and performance results such as “Adjusted EPS,” “Adjusted Operating Income,” “Adjusted EBITDA,” “Adjusted Income before Taxes,” “Adjusted Income Tax Provision,” “Adjusted Effective Income Tax Rate,” “Free Cash Flow less Product Development Spending,” “organic revenue,” and results on a Constant Currency basis to assess underlying business performance and trends.
Management believes non-GAAP financial measures, which exclude the impact of restructuring charges and credits and certain other items, and the impact of divestitures and acquisitions provide a useful comparable basis to analyze operating results and earnings.
See the reconciliations of non-GAAP financial measures and explanations of the uses of non-GAAP measures in the supplementary information.
We have not provided our 2027 outlook for the most directly comparable U.S. GAAP financial measures, as they are not available without unreasonable effort due to the high variability, complexity, and low visibility with respect to certain items, including restructuring charges and credits, acquisition and integration related costs, gains and losses on foreign currency, and other gains and losses.
These items are uncertain, depend on various factors, and could be material to our consolidated results computed in accordance with U.S. GAAP.
Financial statements
Income Statement
Three Months Ended July 31, — (unaudited)
| Three Months Ended July 31, – 2026 | Three Months Ended July 31, – 2025 | ||
|---|---|---|---|
| Revenue, net | 386,361 | 396,800 | |
| Costs and expenses: | Cost of sales | 100,871 | 109,259 |
| Costs and expenses: | Operating and administrative expenses | 238,534 | 240,330 |
| Costs and expenses: | Acquisition and integration related costs(3) | 11,039 | |
| Costs and expenses: | Restructuring and related charges | 16,525 | 3,038 |
| Costs and expenses: | Amortization of intangible assets | 16,455 | 13,210 |
| Costs and expenses: | Total costs and expenses | 383,424 | 365,837 |
| Costs and expenses: | Operating income | 2,937 | 30,963 |
| Costs and expenses: | As a % of revenue | 0.8 | 7.8 |
| Costs and expenses: | Interest expense | -13,926 | -11,042 |
| Costs and expenses: | Net foreign exchange transaction losses | -397 | -971 |
| Costs and expenses: | Net gain (loss) on sale of businesses and assets | 1,113 | -1,116 |
| Costs and expenses: | Other expense, net | -2,304 | -127 |
| Costs and expenses: | (Loss) income before taxes | -12,577 | 17,707 |
| Costs and expenses: | (Benefit) provision for income taxes | -850 | 6,007 |
| Costs and expenses: | Effective tax rate | 6.8 | 33.9 |
| Costs and expenses: | Net (loss) income | -11,727 | 11,700 |
| Costs and expenses: | As a % of revenue | -3 | 2.9 |
| (Loss) earnings per share | Basic | -0.23 | 0.22 |
| (Loss) earnings per share | Diluted(4) | -0.23 | 0.22 |
| Weighted average number of common shares outstanding | Basic | 50,752 | 53,377 |
| Weighted average number of common shares outstanding | Diluted(4) | 50,752 | 53,966 |
Income Statement
(unaudited)
| Reconciliation of US GAAP (Loss) Earnings per Share to Non-GAAP Adjusted EPS – Three Months Ended July 31, – 2026 | Three Months Ended July 31, – 2026 | Reconciliation of US GAAP (Loss) Earnings per Share to Non-GAAP Adjusted EPS – Three Months Ended July 31, – 2026 | Three Months Ended July 31, – 2026 | Reconciliation of US GAAP (Loss) Earnings per Share to Non-GAAP Adjusted EPS – Three Months Ended July 31, – 2025 | Three Months Ended July 31, – 2025 | ||
|---|---|---|---|---|---|---|---|
| US GAAP (Loss) Earnings Per Share - Diluted | -0.23 | 0.22 | |||||
| Adjustments: | Acquisition and integration related costs | 0.2 | |||||
| Adjustments: | Restructuring and related charges | 0.26 | 0.05 | ||||
| Adjustments: | Amortization of acquired intangible assets | 0.24 | 0.2 | ||||
| Adjustments: | Net (gain) loss on sale of businesses and assets | -0.02 | 0.02 | ||||
| Adjustments: | EPS impact of using weighted-average dilutive shares for adjusted EPS calculation(3) | -0.01 | |||||
| Adjustments: | Non-GAAP Adjusted Earnings Per Share - Diluted | 0.44 | 0.49 | ||||
| Reconciliation of US GAAP (Loss) Income Before Taxes to Non-GAAP Adjusted Income Before Taxes | US GAAP (Loss) Income Before Taxes | -12,577 | 17,707 | ||||
| Pretax Impact of Adjustments: | Acquisition and integration related costs | 11,039 | |||||
| Pretax Impact of Adjustments: | Restructuring and related charges | 16,525 | 3,038 | ||||
| Pretax Impact of Adjustments: | Foreign exchange losses (gains) on intercompany transactions | 16 | -440 | ||||
| Pretax Impact of Adjustments: | Amortization of acquired intangible assets | 16,455 | 13,210 | ||||
| Pretax Impact of Adjustments: | Net (gain) loss on sale of businesses and assets | -1,113 | 1,116 | ||||
| Pretax Impact of Adjustments: | Non-GAAP Adjusted Income Before Taxes | 30,345 | 34,631 | ||||
| Reconciliation of US GAAP Income Tax (Benefit) Provision to Non-GAAP Adjusted Income Tax Provision, including our US GAAP Effective Tax Rate and our Non-GAAP Adjusted Effective Tax Rate | US GAAP Income Tax (Benefit) Provision | -850 | 6,007 | ||||
| Income Tax Impact of Adjustments(4) | Acquisition and integration related costs | 936 | |||||
| Income Tax Impact of Adjustments(4) | Restructuring and related charges | 3,313 | 519 | ||||
| Income Tax Impact of Adjustments(4) | Foreign exchange losses (gains) on intercompany transactions | 10 | -750 | ||||
| Income Tax Impact of Adjustments(4) | Amortization of acquired intangible assets | 4,327 | 2,068 | ||||
| Income Tax Impact of Adjustments(4) | Net (gain) loss on sale of businesses and assets | -259 | 54 | ||||
| Income Tax Adjustments | Impact of valuation allowance on the US GAAP effective tax rate | 166 | |||||
| Income Tax Adjustments | Non-GAAP Adjusted Income Tax Provision | 7,477 | 8,064 | ||||
| Income Tax Adjustments | US GAAP Effective Tax Rate | 6.8 | 33.9 | ||||
| Income Tax Adjustments | Non-GAAP Adjusted Effective Tax Rate | 24.6 | 23.3 |
Income Statement
Three Months Ended July 31, — (unaudited)
| Three Months Ended July 31, – 2026 | Three Months Ended July 31, – 2025 | |
|---|---|---|
| Net (Loss) Income | -11,727 | 11,700 |
| Interest expense | 13,926 | 11,042 |
| (Benefit) provision for income taxes | -850 | 6,007 |
| Depreciation and amortization | 37,321 | 36,446 |
| Non-GAAP EBITDA | 38,670 | 65,195 |
| Acquisition and integration related costs | 11,039 | |
| Restructuring and related charges | 16,525 | 3,038 |
| Net foreign exchange transaction losses | 397 | 971 |
| Net (gain) loss on sale of businesses and assets | -1,113 | 1,116 |
| Other expense, net | 2,304 | 127 |
| Non-GAAP Adjusted EBITDA | 67,822 | 70,447 |
| Adjusted EBITDA Margin | 17.6 | 17.8 |
Income Statement
(unaudited)
| Three Months Ended July 31, – 2026 | Three Months Ended July 31, – 2025 | % Change – Favorable (Unfavorable) – Reported | % Change – Favorable (Unfavorable) – Constant Currency | ||
|---|---|---|---|---|---|
| Revenue, net | Research Publishing | 258,886 | 231,827 | 12.0% | 12.0% |
| Revenue, net | Research Solutions | 34,604 | 49,865 | -31.0% | -30.0% |
| Revenue, net | Total Revenue, net | 293,490 | 281,692 | 4.0% | 4.0% |
| Revenue, net | Non-GAAP Adjusted Operating Income | 60,977 | 56,248 | 8.0% | 8.0% |
| Revenue, net | Depreciation and amortization | 25,919 | 23,385 | -11.0% | -11.0% |
| Revenue, net | Non-GAAP Adjusted EBITDA | 86,896 | 79,633 | 9.0% | 9.0% |
Balance Sheet
(unaudited)
| July 31, 2026 | April 30, 2026 | ||
|---|---|---|---|
| Current assets | Cash and cash equivalents | 106,426 | 75,622 |
| Current assets | Accounts receivable, net | 210,729 | 244,164 |
| Current assets | Inventories, net | 18,472 | 19,265 |
| Current assets | Prepaid expenses and other current assets | 102,595 | 80,614 |
| Current assets | Total current assets | 438,222 | 419,665 |
| Current assets | Technology, property and equipment, net | 131,564 | 136,260 |
| Current assets | Intangible assets, net | 853,303 | 578,959 |
| Current assets | Goodwill | 1,390,757 | 1,132,392 |
| Current assets | Operating lease right-of-use assets | 56,478 | 57,128 |
| Current assets | Other non-current assets | 262,075 | 267,414 |
| Current assets | Total assets | 3,132,399 | 2,591,818 |
| Current liabilities | Accounts payable | 44,935 | 67,199 |
| Current liabilities | Accrued royalties | 101,948 | 97,791 |
| Current liabilities | Short-term portion of long-term debt | 13,750 | 12,500 |
| Current liabilities | Contract liabilities | 384,278 | 451,423 |
| Current liabilities | Accrued employment costs | 56,129 | 71,068 |
| Current liabilities | Short-term portion of operating lease liabilities | 16,111 | 15,954 |
| Current liabilities | Other accrued liabilities | 71,671 | 63,012 |
| Current liabilities | Total current liabilities | 688,822 | 778,947 |
| Current liabilities | Long-term debt | 1,277,516 | 670,897 |
| Current liabilities | Accrued pension liability | 58,740 | 59,527 |
| Current liabilities | Deferred income tax liabilities | 165,492 | 98,972 |
| Current liabilities | Operating lease liabilities | 67,493 | 69,544 |
| Current liabilities | Other long-term liabilities | 77,297 | 65,689 |
| Current liabilities | Total liabilities | 2,335,360 | 1,743,576 |
| Current liabilities | Shareholders' equity | 797,039 | 848,242 |
| Current liabilities | Total liabilities and shareholders' equity | 3,132,399 | 2,591,818 |
Cash Flow
Three Months Ended July 31, — (unaudited)
| Three Months Ended July 31, – 2026 | Three Months Ended July 31, – 2025 | ||
|---|---|---|---|
| Operating activities: | Net (loss) income | -11,727 | 11,700 |
| Operating activities: | Net (gain) loss on sale of businesses and assets | -1,113 | 1,116 |
| Operating activities: | Amortization of intangible assets | 16,455 | 13,210 |
| Operating activities: | Amortization of product development assets | 3,652 | 3,792 |
| Operating activities: | Depreciation and amortization of technology, property, and equipment | 17,214 | 19,444 |
| Operating activities: | Other noncash charges | 49,089 | 19,274 |
| Operating activities: | Net change in operating assets and liabilities | -128,842 | -153,541 |
| Operating activities: | Net cash used in operating activities | -55,272 | -85,005 |
| Investing activities: | Additions to technology, property, and equipment | -11,197 | -12,005 |
| Investing activities: | Product development spending | -3,180 | -2,890 |
| Investing activities: | Businesses acquired in purchase transactions, net of cash acquired | -450,351 | |
| Investing activities: | Net cash (transferred) proceeds related to the sale of businesses and assets | -27 | 115,168 |
| Investing activities: | Acquisitions of publication rights and other | -625 | -1,417 |
| Investing activities: | Net cash (used in) provided by investing activities | -465,380 | 98,856 |
| Financing activities: | Net debt borrowings | 609,066 | 30,591 |
| Financing activities: | Cash dividends | -18,167 | -18,985 |
| Financing activities: | Purchases of treasury shares | -15,229 | -13,500 |
| Financing activities: | Other | -22,792 | -15,030 |
| Financing activities: | Net cash provided by (used in) financing activities | 552,878 | -16,924 |
| Financing activities: | Effects of exchange rate changes on cash, cash equivalents and restricted cash | -1,422 | -959 |
| Financing activities: | Change in cash, cash equivalents and restricted cash for period | 30,804 | -4,032 |
| Financing activities: | Cash, cash equivalents and restricted cash - beginning | 75,672 | 85,932 |
| Financing activities: | Cash, cash equivalents and restricted cash - ending | 106,476 | 81,900 |
| CALCULATION OF NON-GAAP FREE CASH FLOW LESS PRODUCT DEVELOPMENT SPENDING (3) | Net cash used in operating activities | -55,272 | -85,005 |
| CALCULATION OF NON-GAAP FREE CASH FLOW LESS PRODUCT DEVELOPMENT SPENDING (3) | Less: Additions to technology, property, and equipment | -11,197 | -12,005 |
| CALCULATION OF NON-GAAP FREE CASH FLOW LESS PRODUCT DEVELOPMENT SPENDING (3) | Less: Product development spending | -3,180 | -2,890 |
Full release
Forward-Looking Statements
This release contains certain forward-looking statements concerning the Company's operations, performance, and financial condition.
Reliance should not be placed on forward-looking statements, as actual results may differ materially from those in any forward-looking statements.
Any such forward-looking statements are based upon a number of assumptions and estimates that are inherently subject to uncertainties and contingencies, many of which are beyond the control of the Company and are subject to change based on many important factors.
Such factors include, but are not limited to: (i) the level of investment in new technologies and products; (ii) subscriber renewal rates for the Company's journals; (iii) the financial stability and liquidity of journal subscription agents; (iv) the consolidation of book wholesalers and retail accounts; (v) the market position and financial stability of key online retailers; (vi) the seasonal nature of the Company's educational business and the impact of the used book market; (vii) worldwide economic and political conditions; (viii) the Company's ability to protect its copyrights and other intellectual property worldwide (ix) the ability of the Company to successfully integrate acquired operations and realize expected synergies and opportunities; (x) the ability to realize operating savings over time and in fiscal year 2027 in connection with our multiyear Global Restructuring Program and completed dispositions; (xi) cyber risk and the failure to maintain the integrity of our operational or security systems or infrastructure, or those of third parties with which we do business; (xii) as a result of acquisitions, we have and may record a significant amount of goodwill and other identifiable intangible assets and we may never realize the full carrying value of these assets; and (xiii) other factors detailed from time to time in the Company's filings with the Securities and Exchange Commission. The Company undertakes no obligation to update or revise forward-looking statements to reflect subsequent events.
Category: Corporate News/ Earnings Releases
JOHN WILEY & SONS, INC.
SUPPLEMENTARY INFORMATION
(1) (2)
CONDENSED CONSOLIDATED STATEMENTS OF NET (LOSS) INCOME
(in USD thousands, except per share information)
(unaudited)
JOHN WILEY & SONS, INC.
SUPPLEMENTARY INFORMATION
(1) (2)
RECONCILIATION OF US GAAP MEASURES to NON-GAAP MEASURES
(in USD thousands, except per share information)
(unaudited)
JOHN WILEY & SONS, INC.
SUPPLEMENTARY INFORMATION
(1) (2)
RECONCILIATION OF US GAAP NET (LOSS) INCOME TO NON-GAAP EBITDA AND ADJUSTED EBITDA
(in USD thousands)
(unaudited)
JOHN WILEY & SONS, INC.
SUPPLEMENTARY INFORMATION
(1) (2) (3)
SEGMENT RESULTS
(in USD thousands)
(unaudited)
JOHN WILEY & SONS, INC.
SUPPLEMENTARY INFORMATION